Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

Schoen MW, Li J, Zeng S, Desai H, Hausler R, Haroldsen CL, Owens L, Valle LF, Etzoni RB, Rebbeck TR, Rose BS, Kelley MJ, Montgomery RB, Nickols NG, Rettig MB, Yamoah K, Maxwell KN, Garraway IP

Open source

DOI: 10.1200/po-26-00021
Published: 2026 Jul
Container: JCO precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po-26-00021,
  title = {Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.},
  author = {Schoen MW and Li J and Zeng S and Desai H and Hausler R and Haroldsen CL and Owens L and Valle LF and Etzoni RB and Rebbeck TR and Rose BS and Kelley MJ and Montgomery RB and Nickols NG and Rettig MB and Yamoah K and Maxwell KN and Garraway IP},
  year = {2026},
  journal = {JCO precision oncology},
  doi = {10.1200/po-26-00021},
  url = {https://doi.org/10.1200/po-26-00021}
}

RIS

TY  - JOUR
TI  - Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.
AU  - Schoen MW
AU  - Li J
AU  - Zeng S
AU  - Desai H
AU  - Hausler R
AU  - Haroldsen CL
AU  - Owens L
AU  - Valle LF
AU  - Etzoni RB
AU  - Rebbeck TR
AU  - Rose BS
AU  - Kelley MJ
AU  - Montgomery RB
AU  - Nickols NG
AU  - Rettig MB
AU  - Yamoah K
AU  - Maxwell KN
AU  - Garraway IP
PY  - 2026
JO  - JCO precision oncology
DO  - 10.1200/po-26-00021
UR  - https://doi.org/10.1200/po-26-00021
ER  -

APA

MW, S., J, L., S, Z., H, D., R, H., CL, H., L, O., LF, V., RB, E., TR, R., BS, R., MJ, K., RB, M., NG, N., MB, R., K, Y., KN, M., & IP, G. (2026). Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.. JCO precision oncology. https://doi.org/10.1200/po-26-00021

Source records

pubmed · retrieved 2026-09-27T14:17:46.819Z